Higher FAM64A expression was observed in HNSCC patients at stage III–IV or with grade G3–G4 compared to those at stage I–II or with grade G1–G2 (Fig. S1h, i). The gene discussed is PIMREG; the disease is head and neck squamous cell carcinoma.